Recent data suggest that circulating levels of PCSK9 increase within hours of the onset of acute coronary syndrome (SCA) and are associated with increased platelet anti-aggregation, the vulnerability of coronary plaque, elevated inflammatory markers, and higher long-term cardiovascular events [29]. The gene discussed is PCSK9; the disease is acute coronary syndrome.